HANLIN BIOTECHNOLOGY - Key Persons
Dr. Zhou Ximing, CEO & chief scientist of Hanlin Biotech, was an associate research scientist in the department of cellular and molecular physiology at Yale school of medicine. He has been working professionally in bio-research since 1997 in the United States with high academic achievements in the field of stem cell culture, the design of serum-free media for suspension culture, research antibody and fully human monoclonal antibody for pain relief and optimized peptide synthesis. He was awarded a Distinguished Expert title in the fourth installment of "Hundred Talents Program" in 2014 in Hebei province.